Grup de Biotecnologia Molecular i Industrial, Centre de Biotecnologia Molecular, Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, Edifici Gaia, Rambla de Sant Nebridi 22, 08222, Terrassa, Catalonia, Spain.
Campo Experimental Bajío, INIFAP, Km 6.5 Carretera Celaya-San Miguel de Allende, Celaya Gto México, CP, 38110, Mexico.
Sci Rep. 2017 Sep 11;7(1):11167. doi: 10.1038/s41598-017-11391-x.
Dietary flavonoids exhibit many biologically-relevant functions and can potentially have beneficial effects in the treatment of pathological conditions. In spite of its well known antioxidant properties, scarce structural information is available on the interaction of flavonoids with membrane receptors. Advances in the structural biology of a specific class of membrane receptors, the G protein-coupled receptors, have significantly increased our understanding of drug action and paved the way for developing improved therapeutic approaches. We have analyzed the effect of the flavonoid quercetin on the conformation, stability and function of the G protein-coupled receptor rhodopsin, and the G90V mutant associated with the retinal degenerative disease retinitis pigmentosa. By using a combination of experimental and computational methods, we suggest that quercetin can act as an allosteric modulator of opsin regenerated with 9-cis-retinal and more importantly, that this binding has a positive effect on the stability and conformational properties of the G90V mutant associated with retinitis pigmentosa. These results open new possibilities to use quercetin and other flavonoids, in combination with specific retinoids like 9-cis-retinal, for the treatment of retinal degeneration associated with retinitis pigmentosa. Moreover, the use of flavonoids as allosteric modulators may also be applicable to other members of the G protein-coupled receptors superfamily.
饮食类黄酮表现出许多与生物学相关的功能,并可能对治疗病理状况有有益的影响。尽管黄酮类化合物具有众所周知的抗氧化特性,但关于它们与膜受体相互作用的结构信息却很少。特定一类膜受体,即 G 蛋白偶联受体的结构生物学的进步,极大地增进了我们对药物作用的理解,并为开发改进的治疗方法铺平了道路。我们分析了类黄酮槲皮素对 G 蛋白偶联受体视紫红质的构象、稳定性和功能的影响,以及与视网膜色素变性相关的 G90V 突变体。通过结合实验和计算方法,我们提出槲皮素可以作为 9-顺式视黄醛再生视蛋白的别构调节剂,更重要的是,这种结合对与视网膜色素变性相关的 G90V 突变体的稳定性和构象特性有积极影响。这些结果为使用槲皮素和其他类黄酮与特定的类视黄醇(如 9-顺式视黄醇)联合治疗与视网膜色素变性相关的视网膜变性开辟了新的可能性。此外,将类黄酮用作别构调节剂也可能适用于 G 蛋白偶联受体超家族的其他成员。